HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Obovatol from Magnolia obovata inhibits vascular smooth muscle cell proliferation and intimal hyperplasia by inducing p21Cip1.

AbstractAIMS:
Obovatol is isolated from Magnolia obovata leaves and this active component has various pharmacological properties such as anti-oxidant, anti-platelet, anti-fungal and anti-inflammatory activities. In the present study, we investigated the inhibitory effects of obovatol on in vitro vascular smooth muscle cell (VSMC) proliferation and in vivo neointimal formation in a rat carotid artery injury model.
METHODS AND RESULTS:
Obovatol (1-5 microM) exerted concentration-dependent inhibition on platelet-derived growth factor (PDGF)-BB-induced rat VSMC proliferation, without exhibiting any cellular toxicity or apoptosis, as determined by cell count, [3H]thymidine incorporation and Annexin-V-binding analyses. Treatment with obovatol blocked the cell cycle in G1 phase by down-regulating the expression of cyclins and CDKs, and selectively up-regulating the expression of p21Cip1, a well-known CDK inhibitor. Effects of perivascular delivery of obovatol were assessed 14 days after injury. The angiographic mean luminal diameters of the obovatol-treated groups (100 microg and 1 mg: 0.78+/-0.06 and 0.77+/-0.07AU, respectively) were significantly larger than that of the control group (0.58+/-0.07AU). The obovatol-treated groups (100 microg and 1mg: 0.14+/-0.04 and 0.09+/-0.03 mm2, respectively) showed significant reduction in neointimal formation versus the control group (0.17+/-0.02 mm2). Immunohistochemical staining demonstrated strong expression of p21Cip1 in the neointima of the obovatol-treated groups.
CONCLUSIONS:
These data suggest that obovatol inhibits VSMC proliferation by perturbing cell cycle progression, possibly due to activation of p21Cip1 pathway. These results also show that obovatol may have potential as an anti-proliferative agent for the treatment of restenosis and atherosclerosis.
AuthorsYong Lim, Jin-Sook Kwon, Dong-Woon Kim, Seung-Ho Lee, Rho-Kwan Park, Jung-Jin Lee, Jin-Tae Hong, Hwan-Soo Yoo, Byoung-Mog Kwon, Yeo-Pyo Yun
JournalAtherosclerosis (Atherosclerosis) Vol. 210 Issue 2 Pg. 372-80 (Jun 2010) ISSN: 1879-1484 [Electronic] Ireland
PMID20022323 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Biphenyl Compounds
  • Cdkn1a protein, rat
  • Cyclin-Dependent Kinase Inhibitor p21
  • Oligonucleotides, Antisense
  • Phenyl Ethers
  • Plant Extracts
  • obovatol
Topics
  • Animals
  • Aorta (pathology)
  • Biphenyl Compounds (pharmacology)
  • Cell Cycle
  • Cell Proliferation
  • Cyclin-Dependent Kinase Inhibitor p21 (metabolism)
  • Disease Progression
  • Magnolia (metabolism)
  • Male
  • Myocytes, Smooth Muscle (cytology)
  • Oligonucleotides, Antisense (pharmacology)
  • Phenyl Ethers (pharmacology)
  • Plant Extracts (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Tunica Intima (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: